Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kei Sakano

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Clinical Investigation|July 8, 2025
ICOS regulates IL-10 production in group 2 innate lymphoid cells via cholesterol and cortisol biosynthesisYoshihiro Sakano, Kei Sakano, Benjamin P Hurrell, et al.
American Journal of Respiratory Cell and Molecular Biology|July 28, 2025
Targeting CD48 Ameliorates ILC2-mediated Airway Hyperreactivity by Disrupting the PKCβ PathwayKei Sakano, Yoshihiro Sakano, Benjamin P Hurrell, et al.
Cell Reports|July 4, 2024
CB2 stimulation of adipose resident ILC2s orchestrates immune balance and ameliorates type 2 diabetes mellitusPedram Shafiei-Jahani, Shi Yan, Mohammad H Kazemi, et al.
Cellular & Molecular Immunology|August 19, 2024
SIRPα engagement regulates ILC2 effector function and alleviates airway hyperreactivity via modulating energy metabolismYoshihiro Sakano, Kei Sakano, Benjamin P Hurrell, et al.
The Journal of Clinical Investigation|January 2, 2025
FOXO1 pathway activation by VISTA immune checkpoint restrains pulmonary ILC2 functionsMohammad Hossein Kazemi, Zahra Momeni-Varposhti, Xin Li, et al.
The Journal of Experimental Medicine|March 26, 2024
Piezo1 channels restrain ILC2s and regulate the development of airway hyperreactivityBenjamin P Hurrell, Stephen Shen, Xin Li, et al.
Nature Communications|April 1, 2026
Tim-3 agonist restrains ILC2 function and attenuates airway hyperreactivity via NLK pathwayYoshihiro Sakano, Kei Sakano, Kota Kokubo, et al.
Science Translational Medicine|May 8, 2024
Iron controls the development of airway hyperreactivity by regulating ILC2 metabolism and effector functionBenjamin P Hurrell, Yoshihiro Sakano, Stephen Shen, et al.
The Journal of Allergy and Clinical Immunology|January 20, 2024
Blocking CD226 regulates type 2 innate lymphoid cell effector function and alleviates airway hyperreactivityYoshihiro Sakano, Kei Sakano, Benjamin P Hurrell, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Clinical Investigation|July 8, 2025
ICOS regulates IL-10 production in group 2 innate lymphoid cells via cholesterol and cortisol biosynthesisYoshihiro Sakano, Kei Sakano, Benjamin P Hurrell, et al.
American Journal of Respiratory Cell and Molecular Biology|July 28, 2025
Targeting CD48 Ameliorates ILC2-mediated Airway Hyperreactivity by Disrupting the PKCβ PathwayKei Sakano, Yoshihiro Sakano, Benjamin P Hurrell, et al.
Cell Reports|July 4, 2024
CB2 stimulation of adipose resident ILC2s orchestrates immune balance and ameliorates type 2 diabetes mellitusPedram Shafiei-Jahani, Shi Yan, Mohammad H Kazemi, et al.
Cellular & Molecular Immunology|August 19, 2024
SIRPα engagement regulates ILC2 effector function and alleviates airway hyperreactivity via modulating energy metabolismYoshihiro Sakano, Kei Sakano, Benjamin P Hurrell, et al.
The Journal of Clinical Investigation|January 2, 2025
FOXO1 pathway activation by VISTA immune checkpoint restrains pulmonary ILC2 functionsMohammad Hossein Kazemi, Zahra Momeni-Varposhti, Xin Li, et al.
The Journal of Experimental Medicine|March 26, 2024
Piezo1 channels restrain ILC2s and regulate the development of airway hyperreactivityBenjamin P Hurrell, Stephen Shen, Xin Li, et al.
Nature Communications|April 1, 2026
Tim-3 agonist restrains ILC2 function and attenuates airway hyperreactivity via NLK pathwayYoshihiro Sakano, Kei Sakano, Kota Kokubo, et al.
Science Translational Medicine|May 8, 2024
Iron controls the development of airway hyperreactivity by regulating ILC2 metabolism and effector functionBenjamin P Hurrell, Yoshihiro Sakano, Stephen Shen, et al.
The Journal of Allergy and Clinical Immunology|January 20, 2024
Blocking CD226 regulates type 2 innate lymphoid cell effector function and alleviates airway hyperreactivityYoshihiro Sakano, Kei Sakano, Benjamin P Hurrell, et al.
Pageof 1